Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma.
Yuichi KibeAtsuya TakedaYuichirou TsurugaiTakahisa EriguchiYohei OkuYuto KimuraNaoki NakamuraPublished in: Acta oncologica (Stockholm, Sweden) (2021)
Marker-less SBRT for HCC achieved favorable local control that fulfilled the threshold. This result suggests that marker-less SBRT with appropriate settings is a feasible treatment strategy.